237 related articles for article (PubMed ID: 32551441)
41. Alteration of circulating miRNAs during myocardial infarction and association with lipid levels.
Ozuynuk-Ertugrul AS; Ekici B; Erkan AF; Coban N
Lab Med; 2024 May; 55(3):361-372. PubMed ID: 38048807
[TBL] [Abstract][Full Text] [Related]
42. Dynamic expression of viral and cellular microRNAs in infectious mononucleosis caused by primary Epstein-Barr virus infection in children.
Gao L; Ai J; Xie Z; Zhou C; Liu C; Zhang H; Shen K
Virol J; 2015 Dec; 12():208. PubMed ID: 26634702
[TBL] [Abstract][Full Text] [Related]
43. Circulating microRNAs as biomarkers of adult Crohn's disease.
Jensen MD; Andersen RF; Christensen H; Nathan T; Kjeldsen J; Madsen JS
Eur J Gastroenterol Hepatol; 2015 Sep; 27(9):1038-44. PubMed ID: 26230660
[TBL] [Abstract][Full Text] [Related]
44. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
45. Identification of Circulating miRNAs Differentially Regulated by Opioid Treatment.
Toyama K; Kiyosawa N; Watanabe K; Ishizuka H
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28926935
[TBL] [Abstract][Full Text] [Related]
46. Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma.
Butz H; Nofech-Mozes R; Ding Q; Khella HWZ; Szabó PM; Jewett M; Finelli A; Lee J; Ordon M; Stewart R; Krylov S; Yousef GM
Eur Urol Focus; 2016 Jun; 2(2):210-218. PubMed ID: 28723537
[TBL] [Abstract][Full Text] [Related]
47. Profiles of serum microRNAs; miR-125b-5p and miR223-3p serve as novel biomarkers for HBV-positive hepatocellular carcinoma.
Giray BG; Emekdas G; Tezcan S; Ulger M; Serin MS; Sezgin O; Altintas E; Tiftik EN
Mol Biol Rep; 2014 Jul; 41(7):4513-9. PubMed ID: 24595450
[TBL] [Abstract][Full Text] [Related]
48. The expression profiles of microRNAs in Kaposi's sarcoma.
Wu XJ; Pu XM; Zhao ZF; Zhao YN; Kang XJ; Wu WD; Zou YM; Wu CY; Qu YY; Zhang DZ; Feng YY; Liu JY
Tumour Biol; 2015 Jan; 36(1):437-46. PubMed ID: 25266797
[TBL] [Abstract][Full Text] [Related]
49. Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs.
Moreno EC; Pascual A; Prieto-Cuadra D; Laza VF; Molina-Cerrillo J; Ramos-Muñoz ME; Rodríguez-Serrano EM; Soto JL; Carrato A; García-Bermejo ML; Guillén-Ponce C
Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30862091
[TBL] [Abstract][Full Text] [Related]
50. Targeting the circulating microRNA signature of obesity.
Ortega FJ; Mercader JM; Catalán V; Moreno-Navarrete JM; Pueyo N; Sabater M; Gómez-Ambrosi J; Anglada R; Fernández-Formoso JA; Ricart W; Frühbeck G; Fernández-Real JM
Clin Chem; 2013 May; 59(5):781-92. PubMed ID: 23396142
[TBL] [Abstract][Full Text] [Related]
51. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
52. Elevated miRNA Inversely Correlates with
Guz M; Dworzański T; Jeleniewicz W; Cybulski M; Kozicka J; Stepulak A; Celiński K
Biomed Res Int; 2020; 2020():4250329. PubMed ID: 32775420
[TBL] [Abstract][Full Text] [Related]
53. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
[TBL] [Abstract][Full Text] [Related]
54. Circulating MicroRNA in inflammatory bowel disease.
Paraskevi A; Theodoropoulos G; Papaconstantinou I; Mantzaris G; Nikiteas N; Gazouli M
J Crohns Colitis; 2012 Oct; 6(9):900-4. PubMed ID: 22386737
[TBL] [Abstract][Full Text] [Related]
55. Identification and validation of endogenous control miRNAs in plasma samples for normalization of qPCR data for Alzheimer's disease.
Dakterzada F; Targa A; Benítez ID; Romero-ElKhayat L; de Gonzalo-Calvo D; Torres G; Moncusí-Moix A; Huerto R; Sánchez-de-la-Torre M; Barbé F; Piñol-Ripoll G
Alzheimers Res Ther; 2020 Dec; 12(1):163. PubMed ID: 33278902
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of miR-526b-3p, miR-1179, miR-3529-3p, miR-5011-5p as potential diagnostic biomarkers in isolated cervical dystonia.
Gelisin O; Susgun S; Toruntay C; Yabaci A; Baran G; Gursoy AEB; Yildiz GB; Yucesan E
Rev Neurol (Paris); 2023 Jun; 179(6):563-569. PubMed ID: 36759300
[TBL] [Abstract][Full Text] [Related]
57. Diabetes induces dysregulation of microRNAs associated with survival, proliferation and self-renewal in cardiac progenitor cells.
Purvis N; Kumari S; Chandrasekera D; Bellae Papannarao J; Gandhi S; van Hout I; Coffey S; Bunton R; Sugunesegran R; Parry D; Davis P; Williams MJA; Bahn A; Katare R
Diabetologia; 2021 Jun; 64(6):1422-1435. PubMed ID: 33655378
[TBL] [Abstract][Full Text] [Related]
58. Cytological effects of honokiol treatment and its potential mechanism of action in non-small cell lung cancer.
Zhang J; Zhang Y; Shen W; Fu R; Ding Z; Zhen Y; Wan Y
Biomed Pharmacother; 2019 Sep; 117():109058. PubMed ID: 31176168
[TBL] [Abstract][Full Text] [Related]
59. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
[TBL] [Abstract][Full Text] [Related]
60. Exosomal miRNAs as Potential Biomarkers to Monitor Phosphodiesterase 5 Inhibitor Induced Anti-Fibrotic Effects on CCl
Broermann A; Schmid R; Gabrielyan O; Sakowski M; Eisele C; Keller S; Wolff M; Baum P; Stierstorfer B; Huber J; Krämer BK; Hocher B; Streicher R; Delić D
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]